Thomas Thevenet
Impact in
- Neurology top 10%
- Neuroblastoma Research and Treatments
-
- Lung Cancer Research Studies
- Pancreatic and Hepatic Oncology Research
- Peptidase Inhibition and Analysis
Papers in
- Oncology 5
- Lung Cancer Research Studies 4
- Cancer Treatment and Pharmacology 1
-
- Neuroendocrine Tumor Research Advances 4
- Herpesvirus Infections and Treatments 1
- Co-authors
- Jonathan Strosberg (1 shared paper)Philippe Ruszniewski (1 shared paper)Richard P. Baum (1 shared paper)Timothy J. Hobday (1 shared paper)Maribel Lopera Sierra (1 shared paper)Kjell Öberg (1 shared paper)Beth Chasen (1 shared paper)Pamela L. Kunz (1 shared paper)
- Journals
- Journal of Clinical Oncology (2 papers)Journal of Dermatological Science (1 paper)Annals of Oncology (1 paper)Endocrine Abstracts (2 papers)PubMed (1 paper)
- Partner nations
- United StatesSpainGermany
In The Last Decade
Thomas Thevenet
5 papers receiving 288 citations
Thomas Thevenet's Hit Papers
Peers
Comparison fields: 5 of 44
- Neurology 160
- Oncology 214
- Epidemiology 237
- Radiology, Nuclear Medicine and Imaging 71
- Pulmonary and Respiratory Medicine 22
Countries citing papers authored by Thomas Thevenet
This map shows the geographic impact of Thomas Thevenet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Thevenet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Thevenet more than expected).
Fields of papers citing papers by Thomas Thevenet
This network shows the impact of papers produced by Thomas Thevenet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Thevenet. The network helps show where Thomas Thevenet may publish in the future.
Co-authors
The 25 scholars most cited alongside Thomas Thevenet, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Health-Related Quality of Life in Patients With Progressive Midgut Neuroendocrine Tumors Treated With 177Lu-Dotatate in the Phase III NETTER-1 Trial Hit paper breakdown → | 2018 | 272 |
| 2 | 2017 | 12 | |
| 3 | Oncostatic effects of Alangium vitiense extracts (ICIG-EORTC 1131, 1186 and 1207) on lymphoid murine tumors. | 1978 | 3 |
| 4 | 2024 | 1 | |
| 5 | 2023 | 1 | |
| 6 | 2023 | 0 | |
| 7 | 2023 | 0 |
About Thomas Thevenet
Thomas Thevenet is a scholar working on Oncology, Epidemiology, Neurology, Pulmonary and Respiratory Medicine and Pharmacology, having authored 7 papers that have together received 289 indexed citations. Recurring topics across this work include Neuroendocrine Tumor Research Advances (4 papers), Lung Cancer Research Studies (4 papers), Neuroblastoma Research and Treatments (4 papers), Cancer Treatment and Pharmacology (1 paper), Medical Imaging Techniques and Applications (1 paper), Medical Imaging and Pathology Studies (1 paper), Herpesvirus Infections and Treatments (1 paper) and Radiopharmaceutical Chemistry and Applications (1 paper). The work is most often cited by research in Neurology (160 citations), Oncology (214 citations), Epidemiology (237 citations), Radiology, Nuclear Medicine and Imaging (71 citations) and Pulmonary and Respiratory Medicine (22 citations). Thomas Thevenet has collaborated with scholars based in United States, Spain and Germany. Frequent co-authors include Jonathan Strosberg, Philippe Ruszniewski, Richard P. Baum, Timothy J. Hobday, Maribel Lopera Sierra, Kjell Öberg, Beth Chasen, Pamela L. Kunz, Eric P. Krenning and Edward M. Wolin. Their work appears in journals such as Journal of Clinical Oncology, Journal of Dermatological Science, Annals of Oncology, Endocrine Abstracts and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.